The phase 2 IGNAZ Trial: Are you or someone you know diagnosed with IgA Nephropathy (IgAN) and interested in learning more about a clinical trial with an investigational treatment option for IgAN which was designed to reduce unwanted auto-antibodies responsible for the development of IgAN?
If yes, please send an email to MorphosysCTHotline@druginfo.com and provide the country, city or state and zip code of your location along with your contact phone number and/or email address. Your information will then be forwarded to a study site close to your place of living, who will reach out to you for evaluation of your eligibility for participation.
FULLY ENROLLED
